Rigel Pharmaceuticals Inc
A South San Francisco biotechnology company that develops and sells prescription medicines for blood disorders and cancer. Its FDA-approved drugs include Tavalisse for immune thrombocytopenia (a low blood-platelet condition) and Rezlidhia for a form of acute myeloid leukemia. Founded in 1996, the company shares its name with Rigel, a brilliant blue star in the Orion constellation whose Arabic name means "the foot of the giant."
Granted 133.9K
Granted 30.5K
Granted 19.4K
Granted 19.5K
Granted 18.9K
Granted 9.8K · Sold 4.0K
Granted 5.8K
Granted 5.8K
Granted 5.8K
Granted 5.8K · Sold 5.0K
Granted 5.8K
Granted 5.8K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Rodriguez Raul RCEO, President, Director · 8 transactions | +16.8% | 279.6K | 133.9K | — | — |
| Schorno Dean LEVP & Chief Financial Officer · 9 transactions | +37.7% | 78.8K | 30.5K | — | — |
| Santos David AEVP, Chief Commercial Officer · 4 transactions | +19.9% | 62.0K | 19.4K | — | — |
| Furey Raymond J.EVP, GC, CCO & Corp Sec · 4 transactions | +31.2% | 50.9K | 19.5K | — | — |
| Rojkjaer LisaEVP, Chief Medical Officer · 3 transactions | +72.5% | 34.0K | 18.9K | — | — |
| Moos Walter HDirector · 3 transactions | +45.2% | 18.5K | 9.8K | — | 4.0K |
| Lapointe Anthony GreggDirector · 1 transaction | +46% | 18.3K | 5.8K | — | — |
| Wasman JaneDirector · 1 transaction | +46% | 18.3K | 5.8K | — | — |
| Hannah Alison L.Director · 1 transaction | +54.1% | 16.4K | 5.8K | — | — |
| Ali-Jackson KamilDirector · 3 transactions | +8% | 10.1K | 5.8K | — | 5.0K |
| Frohlich Mark WDirector · 1 transaction | +460% | 7.0K | 5.8K | — | — |
| Miller Michael PatrickDirector · 1 transaction | — | 5.9K | 5.8K | — | — |
Select a row to see that insider’s individual transactions.
Net open-market activity over the last year: -9.0K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.